Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
Please note that the ANZCTR website will be unavailable from 9am until 12:30pm (AEDT) on Tuesday 17th November for website maintenance.
Please be sure to log out of the system in order to avoid any loss of data. Thank you and apologies for any inconvenience caused.
A database of clinical trials and their results from Australia, New Zealand, and other countries.
account_circle
Log in
to register or update your trial
search
Search for trials
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12626001365358p
Ethics application status
Not yet submitted
Date submitted
7/10/2026
Date registered
16/11/2026
Date last updated
16/11/2026
Date data sharing statement initially provided
16/11/2026
Type of registration
Prospectively registered
Titles & IDs
Public title
Effect of Intense Pulsed Light (IPL) Treatment on Vascularity and Hypertrophic Scarring in Adult Burn Donor Sites
Query!
Scientific title
Effect of Intense Pulsed Light (IPL) on Vascularity and Hypertrophic Scar Development in Burn Donor Sites: A Randomised Controlled Trial Using Objective Imaging with the Antera 3D System
Query!
Additional trial identifiers [1]
318596
0
nil
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Related trial records
Query!
Health condition
Health condition(s) studied:
Burns Scar
343797
0
Query!
Condition category
Condition code
Injuries and Accidents
339934
339934
0
0
Query!
Burns
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of the intervention or exposure
Intervention ( clinical trial )
Intense Pulsed Light (IPL) therapy applied to burn split-thickness skin graft donor-site scars. IPL is a light-based energy device that delivers pulses of broad-spectrum light to the skin. The light energy is absorbed by hemoglobin within blood vessels and converted to heat.
Who delivers it:
IPL treatment will be delivered by appropriately trained and credentialled clinicians within the Victorian Adult Burns Service.
How it is delivered:
Individual, face-to-face treatment. One donor-site area will receive IPL in addition to standard scar management, while a comparable donor-site area will receive standard scar management alone as the intra-subject control. Each treatment session will take approximately 10 to 20 minutes.
Frequency and duration:
Three IPL treatment sessions will be administered approximately 8 weeks apart, commencing 12 weeks after complete epithelialisation. Participants will be followed for 12 months after the final treatment session.
Where:
IPL treatment will be performed in the theatre/day procedure setting at The Alfred Hospital. Scar assessments and follow-up will be undertaken through the Victorian Adult Burns Service.
Adherence:
Attendance at treatment and follow-up appointments will be monitored. Participants will receive instructions regarding standard scar management and aftercare, with adherence discussed at follow-up visits. Appointment reminders will occur through usual hospital processes.
Aftercare:
Standard burn scar management and aftercare will be provided in accordance with routine clinical practice. This may include moisturising, massage, movement exercises, pressure therapy, and skin protection measures, as clinically indicated.
Query!
Intervention code [1]
335503
0
Treatment: Devices
Query!
Intervention code [2]
335734
0
Treatment: Other
Query!
Description of the comparator or control
Comparator: Standard scar management alone, without IPL treatment. This will include routine moisturising, scar massage, silicone therapy and sun protection, with compression therapy where clinically indicated.
Who delivers it: Standard scar management will be provided and supported by appropriately trained members of the Victorian Adult Burns Service clinical team.
How it is delivered: Individual, face-to-face care, with participants continuing their usual scar management at home.
Frequency and duration: three 10-20 mins treatment sessions commencing 12 weeks after complete epithelialisation Standard scar management will continue throughout the study period, from baseline through to the 12-month follow-up after the final IPL treatment.
Where: Scar management education which includes, hydration with moisturising, massage, silicone therapy and assessment will occur through the Victorian Adult Burns Service. Participants will undertake routine scar care at home as above included in scar management education and also SPF protection
Adherence: Adherence to standard scar management will be discussed and monitored during study assessments and follow-up appointments. Participants will receive usual clinical instructions and appointment reminders.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
347102
0
Change in scar vascularity, objectively measured by haemoglobin concentration using the Antera 3D imaging system.
Query!
Assessment method [1]
347102
0
Scar vascularity will be objectively measured using the Antera 3D imaging system, with haemoglobin concentration used as the quantitative measure of vascularity. Measurements will be taken from both the IPL-treated and intra-subject control areas and compared over time.
Query!
Timepoint [1]
347102
0
12 months following the final IPL treatment. This allows assessment of the longer-term effect of IPL on scar vascularity.
Query!
Secondary outcome [1]
468949
0
Scar quality – measured using the Patient and Observer Scar Assessment Scale (POSAS) 3.0.
Query!
Assessment method [1]
468949
0
Scar quality will be assessed using the Patient and Observer Scar Assessment Scale (POSAS) 3.0, incorporating both patient-reported and observer-rated scar characteristics.
Query!
Timepoint [1]
468949
0
Assessment at baseline (12 weeks following complete epithelialisation) and at 3, 6 and 12 months following the final IPL treatment.
Query!
Secondary outcome [2]
470436
0
Health-related quality of life
Query!
Assessment method [2]
470436
0
EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L).
Query!
Timepoint [2]
470436
0
Baseline (prior to treatment), before each treatment session, and at follow-up assessments up to 12 months after the final treatment session.
Query!
Eligibility
Key inclusion criteria
Adults aged 18 years or older.
Patient receiving care through the Victorian Adult Burns Service.
Healed split-thickness skin graft (STSG) donor site 12 weeks to 12 months following complete epithelialisation.
Evidence of increased vascularity and active scar remodelling or early hypertrophic scarring.
Fitzpatrick skin type III–VI.
Two comparable donor-site areas within the same anatomical region suitable for intra-subject comparison.
Able to provide informed consent and comply with study treatment and follow-up requirements
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Healthy volunteers
No
Query!
Key exclusion criteria
Age under 18 years.
Unable to provide informed consent or comply with study requirements.
Fitzpatrick skin type I–II.
Mature donor-site scar without evidence of active remodelling.
Previous scar-directed treatment to the study area, including laser, IPL, corticosteroid injection, microneedling or surgical revision.
Active wound breakdown or infection.
Dermatological conditions affecting pigmentation, vascularity or wound healing.
Photosensitivity disorders or use of relevant photosensitising medications.
Pregnancy or breastfeeding.
Skin malignancy within the treatment area.
Unable to obtain reliable Antera 3D imaging or attend required follow-up.
Any other clinical condition making IPL treatment unsuitable or likely to affect study outcomes
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
To be confirmed with the research/PowerTrials team prior to study commencement.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Computer-generated random sequence with 1:1 allocation of the two comparable donor-site areas to IPL treatment or standard scar management.
Query!
Masking / blinding
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
2/12/2026
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
20
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Recruitment hospital [1]
30330
0
The Alfred - Melbourne
Query!
Recruitment postcode(s) [1]
46743
0
3004 - Melbourne
Query!
Funding & Sponsors
Funding source category [1]
323170
0
Hospital
Query!
Name [1]
323170
0
The Alfred Hospital
Query!
Address [1]
323170
0
Query!
Country [1]
323170
0
Australia
Query!
Primary sponsor type
Hospital
Query!
Name
The Alfred Hospital
Query!
Address
Query!
Country
Australia
Query!
Secondary sponsor category [1]
326138
0
None
Query!
Name [1]
326138
0
Query!
Address [1]
326138
0
Query!
Country [1]
326138
0
Query!
Ethics approval
Ethics application status
Not yet submitted
Query!
Ethics committee name [1]
321576
0
Alfred Hospital Ethics Committee
Query!
Ethics committee address [1]
321576
0
https://www.alfredhealth.org.au/research/ethics-research-governance
Query!
Ethics committee country [1]
321576
0
Australia
Query!
Date submitted for ethics approval [1]
321576
0
20/11/2026
Query!
Approval date [1]
321576
0
Query!
Ethics approval number [1]
321576
0
Query!
Summary
Brief summary
This prospective, intra-subject controlled randomised trial will evaluate the effect of Intense Pulsed Light (IPL) therapy on vascularity and hypertrophic scarring in adult burn donor sites. Twenty adults treated through the Victorian Adult Burns Service will participate, with each participant having two comparable donor-site areas allocated to either IPL plus standard scar management or standard scar management alone. IPL treatment will commence 12 weeks after complete epithelialisation, with three treatment sessions delivered at eight-week intervals. Scar vascularity will be objectively assessed using Antera 3D imaging, with scar quality assessed using POSAS 3.0 and health-related quality of life using EQ-5D. Participants will be followed for 12 months after the final IPL treatment to assess longer-term scar outcomes.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
154130
0
Mrs Sally NG
Query!
Address
154130
0
The Alfred Hospital 55 Commercial Road, Melbourne, VIC 3004
Query!
Country
154130
0
Australia
Query!
Phone
154130
0
+61 427020784
Query!
Fax
154130
0
Query!
Email
154130
0
[email protected]
Query!
Contact person for public queries
Name
154131
0
Sally NG
Query!
Address
154131
0
The Alfred Hospital 55 Commercial Road, Melbourne, VIC 3004
Query!
Country
154131
0
Australia
Query!
Phone
154131
0
+61 427020784
Query!
Fax
154131
0
Query!
Email
154131
0
[email protected]
Query!
Contact person for scientific queries
Name
154132
0
Sally NG
Query!
Address
154132
0
The Alfred Hospital 55 Commercial Road, Melbourne, VIC 3004
Query!
Country
154132
0
Australia
Query!
Phone
154132
0
+61 427020784
Query!
Fax
154132
0
Query!
Email
154132
0
[email protected]
Query!
Data sharing statement
Will the study consider sharing individual participant data?
No
What supporting documents are/will be available?
No Supporting Document Provided
Type
Citation
Link
Email
Other Details
Attachment
Ethical approval
[email protected]
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF